207 related articles for article (PubMed ID: 29437613)
1. Evolution of the Pseudomonas aeruginosa Aminoglycoside Mutational Resistome
López-Causapé C; Rubio R; Cabot G; Oliver A
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437613
[TBL] [Abstract][Full Text] [Related]
2. Mutations in Gene
Bolard A; Plésiat P; Jeannot K
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133559
[TBL] [Abstract][Full Text] [Related]
3. Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis clone.
López-Causapé C; Sommer LM; Cabot G; Rubio R; Ocampo-Sosa AA; Johansen HK; Figuerola J; Cantón R; Kidd TJ; Molin S; Oliver A
Sci Rep; 2017 Jul; 7(1):5555. PubMed ID: 28717172
[TBL] [Abstract][Full Text] [Related]
4. Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
Vogne C; Aires JR; Bailly C; Hocquet D; Plésiat P
Antimicrob Agents Chemother; 2004 May; 48(5):1676-80. PubMed ID: 15105120
[TBL] [Abstract][Full Text] [Related]
5. MexXY efflux pump overexpression and aminoglycoside resistance in cystic fibrosis isolates of Pseudomonas aeruginosa from chronic infections.
Singh M; Yau YCW; Wang S; Waters V; Kumar A
Can J Microbiol; 2017 Dec; 63(12):929-938. PubMed ID: 28922614
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Islam S; Oh H; Jalal S; Karpati F; Ciofu O; Høiby N; Wretlind B
Clin Microbiol Infect; 2009 Jan; 15(1):60-6. PubMed ID: 19154484
[TBL] [Abstract][Full Text] [Related]
7. Draft genome sequence of an aminoglycoside-resistant RmtG-producing Pseudomonas aeruginosa ST235 isolated from a cystic fibrosis patient.
Bueno MFC; Francisco GR; Cerdeira L; Ienne S; Souza TA; Lincopan N; de Oliveira Garcia D
J Glob Antimicrob Resist; 2017 Mar; 8():106-107. PubMed ID: 28082143
[TBL] [Abstract][Full Text] [Related]
8. Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment.
MacLeod DL; Nelson LE; Shawar RM; Lin BB; Lockwood LG; Dirk JE; Miller GH; Burns JL; Garber RL
J Infect Dis; 2000 Mar; 181(3):1180-4. PubMed ID: 10720551
[TBL] [Abstract][Full Text] [Related]
9. Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing.
Cabot G; López-Causapé C; Ocampo-Sosa AA; Sommer LM; Domínguez MÁ; Zamorano L; Juan C; Tubau F; Rodríguez C; Moyà B; Peña C; Martínez-Martínez L; Plesiat P; Oliver A
Antimicrob Agents Chemother; 2016 Dec; 60(12):7415-7423. PubMed ID: 27736752
[TBL] [Abstract][Full Text] [Related]
10. Genetic determinants of antimicrobial resistance in polymyxin B resistant Pseudomonas aeruginosa isolated from airways of patients with cystic fibrosis.
Simão FA; Almeida MM; Rosa HS; Marques EA; Leão RS
Braz J Microbiol; 2024 Jun; 55(2):1415-1425. PubMed ID: 38619733
[TBL] [Abstract][Full Text] [Related]
11. Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.
Aghazadeh M; Hojabri Z; Mahdian R; Nahaei MR; Rahmati M; Hojabri T; Pirzadeh T; Pajand O
Infect Genet Evol; 2014 Jun; 24():187-92. PubMed ID: 24694825
[TBL] [Abstract][Full Text] [Related]
12. Diffusion and Characterization of Pseudomonas aeruginosa Aminoglycoside Resistance in an Italian Regional Cystic Fibrosis Centre.
Mangiaterra G; Cedraro N; Citterio B; Simoni S; Vignaroli C; Biavasco F
Adv Exp Med Biol; 2021; 1323():71-80. PubMed ID: 32654097
[TBL] [Abstract][Full Text] [Related]
13. Aminoglycoside resistance mechanisms in Pseudomonas aeruginosa isolates from non-cystic fibrosis patients in Thailand.
Poonsuk K; Tribuddharat C; Chuanchuen R
Can J Microbiol; 2013 Jan; 59(1):51-6. PubMed ID: 23391230
[TBL] [Abstract][Full Text] [Related]
14. Hypermutator Pseudomonas aeruginosa Exploits Multiple Genetic Pathways To Develop Multidrug Resistance during Long-Term Infections in the Airways of Cystic Fibrosis Patients.
Colque CA; Albarracín Orio AG; Feliziani S; Marvig RL; Tobares AR; Johansen HK; Molin S; Smania AM
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071060
[No Abstract] [Full Text] [Related]
15. Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain.
Del Barrio-Tofiño E; López-Causapé C; Cabot G; Rivera A; Benito N; Segura C; Montero MM; Sorlí L; Tubau F; Gómez-Zorrilla S; Tormo N; Durá-Navarro R; Viedma E; Resino-Foz E; Fernández-Martínez M; González-Rico C; Alejo-Cancho I; Martínez JA; Labayru-Echverria C; Dueñas C; Ayestarán I; Zamorano L; Martinez-Martinez L; Horcajada JP; Oliver A
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874376
[TBL] [Abstract][Full Text] [Related]
16. Evolved Aztreonam Resistance Is Multifactorial and Can Produce Hypervirulence in
Jorth P; McLean K; Ratjen A; Secor PR; Bautista GE; Ravishankar S; Rezayat A; Garudathri J; Harrison JJ; Harwood RA; Penewit K; Waalkes A; Singh PK; Salipante SJ
mBio; 2017 Oct; 8(5):. PubMed ID: 29089424
[TBL] [Abstract][Full Text] [Related]
17. Role of the MexXY multidrug efflux pump in moderate aminoglycoside resistance in Pseudomonas aeruginosa isolates from Pseudomonas mastitis.
Chuanchuen R; Wannaprasat W; Ajariyakhajorn K; Schweizer HP
Microbiol Immunol; 2008 Aug; 52(8):392-8. PubMed ID: 18667038
[TBL] [Abstract][Full Text] [Related]
18. Molecular Epidemiology of Mutations in Antimicrobial Resistance Loci of Pseudomonas aeruginosa Isolates from Airways of Cystic Fibrosis Patients.
Greipel L; Fischer S; Klockgether J; Dorda M; Mielke S; Wiehlmann L; Cramer N; Tümmler B
Antimicrob Agents Chemother; 2016 Nov; 60(11):6726-6734. PubMed ID: 27572404
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress induction of the MexXY multidrug efflux genes and promotion of aminoglycoside resistance development in Pseudomonas aeruginosa.
Fraud S; Poole K
Antimicrob Agents Chemother; 2011 Mar; 55(3):1068-74. PubMed ID: 21173187
[TBL] [Abstract][Full Text] [Related]
20. Parallel Evolution of Tobramycin Resistance across Species and Environments.
Scribner MR; Santos-Lopez A; Marshall CW; Deitrick C; Cooper VS
mBio; 2020 May; 11(3):. PubMed ID: 32457248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
